Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Corrective Advertising Study From FDA To Examine Similarity Of Message

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA’s proposed study will assess how exposure to a corrective television ad affects consumer misperceptions about the product.

You may also be interested in...



Labeling Regs Feel Ripple Effects From FDA’s Capsized Cigarette Warnings

A judge’s opinion that requiring graphic images on cigarette packages unconstitutionally compels speech could apply to FDA off-label rules and disclosure requirements.

DTC Decennial Survey: FDA Adds Nurses, Physician Assistants To Queries On Ads

The survey will update findings from a 2002 assessment by physicians on the impact of DTC marketing on their interactions with patients.

Two Companies, Two BARDA Contracts, Two Approaches To Coronavirus

Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.

Topics

Related Companies

UsernamePublicRestriction

Register

PS073839

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel